Androgen class drugs

8 results
  • androgel

    (Testosterone)
    ASCEND Therapeutics U.S., LLC
    AndroGel 1.62% is indicated for testosterone replacement therapy in adult males with primary or hypogonadotropic hypogonadism due to various conditions. Its safety and efficacy in age-related hypogonadism and in males under 18 have not been established.
  • jatenzo

    (testosterone undecanoate)
    TOLMAR Inc.
    JATENZO (testosterone undecanoate) is indicated for testosterone replacement therapy in adult males with conditions leading to low testosterone, including primary and hypogonadotropic hypogonadism. It is not established for safety and efficacy in males under 18 years old.
  • natesto

    (testosterone)
    Acerus Pharmaceuticals Corporation
    Natesto is indicated for testosterone replacement therapy in adult males with primary or hypogonadotropic hypogonadism due to various causes, such as testicular failure or pituitary-hypothalamic injury. Its safety and efficacy in age-related hypogonadism and in males under 18 years have not been established.
  • testosterone

    (Testosterone)
    Actavis Pharma, Inc.
    Testosterone topical solution is indicated for replacement therapy in males with primary or hypogonadotropic hypogonadism due to conditions such as testicular failure or pituitary-hypothalamic injury. Its safety and efficacy in age-related hypogonadism or in males under 18 have not been established.
  • testosterone

    (Testosterone)
    Lupin Pharmaceuticals, Inc.
    Testosterone gel 1.62% is indicated for replacement therapy in adult males with primary or hypogonadotropic hypogonadism associated with endogenous testosterone deficiency. It is not established for age-related hypogonadism or in males under 18 years. Different topical testosterone products may have varying dosages and instructions.
  • testosterone

    (Testosterone)
    Actavis Pharma, Inc.
    Testosterone gel 1.62% is indicated for replacement therapy in adult males with primary or hypogonadotropic hypogonadism due to conditions causing low testosterone levels. Its safety and efficacy are not established for age-related hypogonadism or in males under 18 years old.
  • testosterone

    (testosterone)
    Actavis Pharma, Inc.
    Testosterone topical gel is indicated for male replacement therapy in cases of primary hypogonadism and hypogonadotropic hypogonadism due to various conditions. It is not established for age-related hypogonadism or for use in males under 18 years old.
  • testosterone

    (testosterone)
    Northstar Rx LLC
    Testosterone Gel, 1.62% is indicated for replacement therapy in adult males with deficiencies or absence of endogenous testosterone due to primary hypogonadism or hypogonadotropic hypogonadism. Safety and efficacy in age-related hypogonadism and males under 18 haven't been established.